Katelyn B. Meyer, PharmD, discusses how payers can prepare for emerging specialty therapies, from cell and gene therapies to costly oncology drugs.
Katelyn B. Meyer, PharmD
Advertisement
Katelyn B. Meyer, PharmD, is a clinical pharmacy manager at MassHealth.
Articles by Katelyn B. Meyer, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Higher Ropeginterferon Alfa-2b Exposure Liked to JAK2 Reductions in ET
2
Medicare Plan Terminations Hit 4.3 Million as Part D Market Shrinks
3
FDA Approves Talazoparib Plus Enzalutamide for HRR-Mutated mHSPC
4
Menin Inhibitors in AML: In NYC, Experts Map the Path From Academic Centers to Community Care
5